Michele T. Yip-Schneider, PhD

Dr. Yip-Schneider is currently Senior Research Professor of Surgery.  She received her PhD in Biochemistry from the University of California, Davis.  Following post-doctoral training at the University of California, Los Angeles and Indiana University School of Medicine, she joined the Department of Surgery faculty in 2001.

Dr. Yip-Schneider’s research focus is on pancreatic cancer and pancreatic cysts, some of which have malignant potential. This work encompasses the search for potential targets, therapeutics, and biomarkers for earlier detection and prevention. She has more than 75 peer reviewed publications.

Yip-Schneider MT, Wu H, Dumas RP, Hancock BA, Agaram N, Radovich M, Schmidt CM:  Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts. J Am Coll Surg 218(4):608-17, 2014.

Yip-Schneider MT, Carr RA, Wu H, Schmidt CM: Prostaglandin E2: A Pancreatic Fluid Biomarker of IPMN Dysplasia. J Am Coll Surg 225(4):481-487, 2017.

Carr RA, Yip-Schneider MT, Simpson RE, Dolejs S, Schneider JG, Wu H, Ceppa EP, Park W, Schmidt CM: Pancreatic Cyst Fluid Glucose: Rapid, Inexpensive, and Accurate Diagnosis of Mucinous Pancreatic Cysts.  Surgery 163(3):600-605, 2018.

Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP, Do KA, Zhang J, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger J, Yip-Schneider MT, Maitra A, Wolpin BM, Hanash S: Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection. Gastroenterology 160(4):1373-1383, 2021.

Yip-Schneider MT, Wu H, Allison HR, Easler JJ, Sherman S, Al-Haddad MA, Dewitt JM, Schmidt CM: Biomarker Risk Score Algorithm and Preoperative Stratification of Patients with Pancreatic Cystic Lesions. J Am Coll Surg 233(3):426-434, 2021.